Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H18ClNO4S |
Molecular Weight | 331.815 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1C[C@@H](C)CN(C1)S(=O)(=O)C2=CC(C(O)=O)=C(Cl)C=C2
InChI
InChIKey=IFXSWTIWFGIXQO-AOOOYVTPSA-N
InChI=1S/C14H18ClNO4S/c1-9-5-10(2)8-16(7-9)21(19,20)11-3-4-13(15)12(6-11)14(17)18/h3-4,6,9-10H,5,7-8H2,1-2H3,(H,17,18)/t9-,10+
Molecular Formula | C14H18ClNO4S |
Molecular Weight | 331.815 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Tibric Acid is a sulfamoylbenzoic acid derivative patented by American multinational pharmaceutical corporation Pfizer Inc. as a hypolipidemic agent. In preclinical models, Tibric acid, given orally, was more effective than clofibrate in preventing the hyperlipemic and hypercholesteremic effects of various diets in rats. At high concentrations in vitro, Tibric acid moderately inhibited ADP- or thrombin-induced aggregation of rabbit blood platelets. In patients with severe type IV hyperlipoproteinemia and chylomicronemia, Tibric Acid lowered serum triglyceride and cholesterol values but administration of Tibric Acid to a normal subject did not affect serum lipid levels.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4617230
500-1500 mg/day
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:14 UTC 2023
by
admin
on
Fri Dec 15 14:59:14 UTC 2023
|
Record UNII |
LK312SQ24Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C152606
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
37087-94-8
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
CHEMBL2104748
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
DTXSID1020277
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
32335
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
LK312SQ24Z
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
253-344-0
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
3291
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
SUB11023MIG
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
C067603
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
100000082165
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY | |||
|
Tibric acid
Created by
admin on Fri Dec 15 14:59:14 UTC 2023 , Edited by admin on Fri Dec 15 14:59:14 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |